Home
Dashboard
About Victoria
Quick Start
LaunchVic Funds & Programs
Companies
Investors
Funding
Startup Jobs
Accelerators
Corporates
Universities
Workspaces
Companies
Helmedix
Portfolio
Exits
Save
Helmedix
Developing novel therapies for autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and multiple sclerosis.
Overview
Similar companies
Investments (0)
Analytics
Notes
Job openings
Innovations (0)
All
Current
Exits
Rounds
Co-Investors
No columns specified